Clinical Trials Insight: 700043596

Trial Profile

Clinical Trials Insight: 700043596

Phase of Trial: Phase I

Latest Information Update: 20 Apr 2009

At a glance

  • Drugs Dronabinol (Primary) ; Dronabinol (Primary)
  • Indications Chemotherapy-induced nausea and vomiting; Neuropathic pain
  • Focus Pharmacokinetics
  • Sponsors Cynapsus Therapeutics; IntelGenx Corp.
  • Most Recent Events

    • 20 Apr 2009 New trial record.
    • 14 Apr 2009 Results reported in a Cannasat Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top